1. Home
  2. KRYS vs SOUN Comparison

KRYS vs SOUN Comparison

Compare KRYS & SOUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KRYS
  • SOUN
  • Stock Information
  • Founded
  • KRYS 2015
  • SOUN 2005
  • Country
  • KRYS United States
  • SOUN United States
  • Employees
  • KRYS N/A
  • SOUN N/A
  • Industry
  • KRYS Biotechnology: Biological Products (No Diagnostic Substances)
  • SOUN EDP Services
  • Sector
  • KRYS Health Care
  • SOUN Technology
  • Exchange
  • KRYS Nasdaq
  • SOUN Nasdaq
  • Market Cap
  • KRYS 4.5B
  • SOUN 5.1B
  • IPO Year
  • KRYS 2017
  • SOUN N/A
  • Fundamental
  • Price
  • KRYS $148.39
  • SOUN $13.64
  • Analyst Decision
  • KRYS Strong Buy
  • SOUN Buy
  • Analyst Count
  • KRYS 7
  • SOUN 6
  • Target Price
  • KRYS $206.67
  • SOUN $13.25
  • AVG Volume (30 Days)
  • KRYS 292.3K
  • SOUN 82.1M
  • Earning Date
  • KRYS 02-24-2025
  • SOUN 02-27-2025
  • Dividend Yield
  • KRYS N/A
  • SOUN N/A
  • EPS Growth
  • KRYS N/A
  • SOUN N/A
  • EPS
  • KRYS 1.77
  • SOUN N/A
  • Revenue
  • KRYS $241,519,000.00
  • SOUN $67,297,000.00
  • Revenue This Year
  • KRYS $485.65
  • SOUN $86.49
  • Revenue Next Year
  • KRYS $58.64
  • SOUN $97.20
  • P/E Ratio
  • KRYS $83.69
  • SOUN N/A
  • Revenue Growth
  • KRYS 2722.80
  • SOUN 76.05
  • 52 Week Low
  • KRYS $107.50
  • SOUN $1.62
  • 52 Week High
  • KRYS $219.34
  • SOUN $24.98
  • Technical
  • Relative Strength Index (RSI)
  • KRYS 37.81
  • SOUN 42.37
  • Support Level
  • KRYS $141.72
  • SOUN $12.41
  • Resistance Level
  • KRYS $152.94
  • SOUN $22.85
  • Average True Range (ATR)
  • KRYS 5.22
  • SOUN 2.14
  • MACD
  • KRYS -0.42
  • SOUN -1.14
  • Stochastic Oscillator
  • KRYS 33.00
  • SOUN 9.92

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

About SOUN SoundHound AI Inc

SoundHound AI Inc is an innovator of conversational intelligence, offering an independent Voice AI platform that enables businesses across industries to deliver high-quality conversational experiences to customers.

Share on Social Networks: